Take the fast lane to preclinical research and development
Redoxis is a full-service CRO with core competence in preclinical drug development and efficacy evaluation in inflammatory, autoimmune and neurodegenerative disease models. From its head office in Medicon Village in Lund, southern Sweden, Redoxis reaches a global market. »